3 Questions: Artificial intelligence for health care equity
Regina Barzilay, Fotini Christia, and Collin Stultz describe how artificial intelligence and machine learning can support fairness, personalization, and inclusiveness in health care.
Regina Barzilay, Fotini Christia, and Collin Stultz describe how artificial intelligence and machine learning can support fairness, personalization, and inclusiveness in health care.
Delivering vaccines directly to the lungs can boost immune responses to respiratory infections or lung cancer, study finds.
Wireless sensing technology could help improve patients’ technique with inhalers and insulin pens.
After studying and working on three continents, senior Andrea Orji now seeks to become a physician, eventually working in Nigeria.
Study finds patients are receptive to interacting with robots designed to evaluate symptoms in a contact-free way.
A strategy for preventing boron-containing compounds from breaking down could help medicinal chemists design new drugs.
Inspired by personal tragedy, graduate student Hyunwoo Yuk used his background in soft materials to develop a bioadhesive tape for repairing damaged tissue.
A new computational approach for analyzing complex datasets shows that as disease progresses, neurons and astrocytes lose the ability to maintain homeostasis.
Improved public health messaging to Black, Latinx, and other communities disproportionately impacted by the pandemic can increase Covid-19 knowledge and information-seeking.
Study suggests forcing bacteria to burn more energy could make them more susceptible to antibiotics.
Trained dogs can detect cancer and other diseases by smell. A miniaturized detector can analyze trace molecules to mimic the process.
Reconnecting muscle pairs during amputation gives patients more sensory feedback from the limb.
The award recognizes Weinberg’s pioneering achievements in the field of cancer biology.
Scalable CRISPRi system from SMART allows scientists to identify and tackle causes of E. faecalis-related diseases and drug resistance.
Biological sensors developed by MIT spinout Glympse Bio could help clinicians make decisions for individual patients.